|
Delayed
OTC Markets
04:06:02 09/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.5078 USD | +4.57% |
|
-0.43% | +12.84% |
| 06/04 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 12/11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.87M 1.76M 1.61M 3M 207M 3.02M 20.89M 8.07M 105M 8.17M 7.99M 334M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.6M 10.92M 9.95M 18.62M 1.28B 18.7M 129M 50.04M 654M 50.62M 49.52M 2.07B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Cyanotech Corporation
| 1 day | +4.57% | ||
| 1 week | -0.43% | ||
| Current month | +20.90% | ||
| 1 month | -4.17% | ||
| 3 months | +15.41% | ||
| 6 months | +23.88% | ||
| Current year | +12.84% |
| 1 week | 0.49 |  | 0.51 |
| 1 month | 0.35 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.23 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/9/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.57% | -0.43% | +95.31% | -37.29% | 3.68M | |
| +0.10% | -2.77% | +49.40% | +89.31% | 1,002B | |
| +0.08% | -3.31% | +53.14% | +65.50% | 644B | |
| +0.52% | -2.73% | +19.59% | +69.82% | 443B | |
| -0.82% | -3.34% | +29.50% | +35.72% | 343B | |
| +0.38% | -14.47% | +11.49% | +27.19% | 262B | |
| +0.34% | -3.84% | -1.96% | +11.22% | 245B | |
| -0.80% | -12.54% | +39.46% | +48.41% | 212B | |
| -0.81% | -5.04% | -18.45% | -58.13% | 199B | |
| -0.82% | -4.42% | +25.41% | +87.60% | 181B | |
| Average | +0.24% | -4.50% | +30.29% | +33.94% | 352.97B | |
| Weighted average by Cap. | -0.09% | -4.24% | +32.39% | +56.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 19.85M 18.69M 17.03M 31.87M 2.2B 31.99M 222M 85.63M 1.12B 86.63M 84.75M 3.54B | 24.22M 20.84M 19.62M 17.88M 33.45M 2.3B 33.58M 233M 89.87M 1.17B 90.93M 88.95M 3.72B |
| Net income | -5.27M -4.53M -4.27M -3.89M -7.28M -501M -7.3M -50.58M -19.55M -255M -19.78M -19.35M -809M | -3.2M -2.76M -2.6M -2.36M -4.42M -305M -4.44M -30.76M -11.89M -155M -12.03M -11.77M -492M |
| Net Debt | 10.2M 8.77M 8.26M 7.53M 14.09M 970M 14.14M 97.92M 37.85M 494M 38.29M 37.46M 1.57B | 11.31M 9.73M 9.16M 8.35M 15.62M 1.08B 15.68M 109M 41.96M 548M 42.46M 41.54M 1.74B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | USD 0.5078 | +4.57% | 141 |
| 04/09/26 | USD 0.4856 | -8.38% | 2,100 |
| 03/09/26 | USD 0.5300 | +3.92% | 11,606 |
| 02/09/26 | USD 0.5100 | +21.43% | 1,220 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
